Test Bank for Clayton’s Basic Pharmacology for Nurses 18th Edition Willihnganz, – by Chapter with Answers |newest update 2026 A+

Test Bank For Basic Pharmacology for Nurses 17th Edition by Michelle Willihnganz, Bruce
w w w w w w w w w w w w



D. Clayton Chapter 1-48
w w w w




TABLE OF CONTENTS. w w



Unit 1: Applying Pharmacology to Nursing Practice
w w w w w w


Chapter 1: Drug Definitions, Standards, and Information Sources
w w w w w w w


Chapter 2: Basic Principles of Drug Action and Drug
w w w w w w w w w


Interactions Chapter 3: Drug Action Across the Life Span
w w w w w w w w w


Chapter 4: The Nursing Process and Pharmacology
w w w w w w


Chapter 5: Patient Education to Promote Health
w w w w w w w



Unit 2: Illustrated Atlas of Medication Administration
w w w w w w


Chapter 6: Principles of Medication Administration and Medication Safety
w w w w w w w w


Chapter 7: Percutaneous Administration
w w w w


Chapter 8: Enteral Administration
w w w


Chapter 9: Parenteral Administration: Safe Preparation of Parenteral Medications
w w w w w w w w


Chapter 10: Parenteral Administration: Intradermal, Subcutaneous, and Intramuscular
w w w w w w w w


Routes
w


Chapter 11: Parenteral Administration: Intravenous Route
w w w w w



Unit 3: Drugs Affecting the Autonomic and Central Nervous Systems
w w w w w w w w w


Chapter 12: Drugs Affecting the Autonomic Nervous System
w w w w w w w


Chapter 13: Drugs Used for Sleep
w w w w w w


Chapter 14: Drugs Used for Neurodegenerative Disorders (NEW!)
w w w w w w w


Chapter 15: Drugs Used for Anxiety Disorders
w w w w w w w


Chapter 16: Drugs Used for Depressive and Bipolar Disorders
w w w w w w w w


Chapter 17: Drugs Used for Psychoses
w w w w w w


Chapter 18: Drugs Used for Seizure Disorders
w w w w w w


Chapter 19: Drugs Used for Pain Management
w w w w w w w



wUnit 4: Drugs Affecting the Cardiovascular
w w w w w



System
w


Chapter 20: Introduction to Cardiovascular Disease and Metabolic Syndrome
w w w w w w w w


Chapter 21: Drugs Used to Treat Dyslipidemias
w w w w w w w


Chapter 22: Drugs Used to Treat Hypertension
w w w w w w


Chapter 23: Drugs Used to Treat Dysrhythmias
w w w w w w w


Chapter 24: Drugs Used to Treat Angina Pectoris
w w w w w w w w


Chapter 25: Drugs Used to Treat Peripheral Vascular Disease
w w w w w w w w


Chapter 26: Drugs Used to Treat Thromboembolic
w w w w w w w


Disorders Chapter 27: Drugs Used to Treat Heart Failure
w w w w w w w w w


Chapter 28: Drugs Used for Diuresis
w w w w w


Unit 5: Drugs Affecting the Respiratory System
w w w w w w


Chapter 29: Drugs Used to Treat Upper Respiratory Disease
w w w w w w w w


Chapter 30: Drugs Used to Treat Lower Respiratory
w w w w w w w w



Disease Unit 6: Drugs Affecting the Digestive System
w w w w w w w w


Chapter 31: Drugs Used to Treat Oral Disorders
w w w w w w w


Chapter 32: Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Disease
w w w w w w w w w w w


Chapter 33: Drugs Used to Treat Nausea and Vomiting
w w w w w w w w w


Chapter 34: Drugs Used to Treat Constipation and Diarrhea
w w w w w w w w



Unit 7: Drugs That Affect the Endocrine System
w w w w w w w


Chapter 35: Drugs Used to Treat Diabetes Mellitus
w w w w w w w w


Chapter 36: Drugs Used to Treat Thyroid Disease
w w w w w w w w


Chapter 37: Corticosteroids
w w w


Chapter 38: Gonadal Hormones
w w w



Unit 8: Drugs Affecting the Reproductive System
w w w w w w


Chapter 39: Drugs Used in Obstetrics
w w w w w


Chapter 40: Drugs Used in Men‘s and Women‘s Health
w w w w w w w w



Unit 9: Drugs Affecting Other Body Systems
w w w w w w


Chapter 41: Drugs Used to Treat Disorders of the Urinary System
w w w w w w w w w w


Chapter 42: Drugs Used to Treat Glaucoma and Other Eye Disorders
w w w w w w w w w w w


Chapter 43: Drugs Used to Treat Cancer
w w w w w w w


Chapter 44: Drugs Used to Treat the Musculoskeletal System
w w w w w w w w


Chapter 45: Drugs Used to Treat Infection Unit 10: Drugs Affecting the General Health of the Body
w w w w w w w w w w w w w w w w


Chapter 46: Nutrition
w w w


Chapter 47: Herbal and Dietary Supplemental Therapy
w w w w w w


Chapter 48: Substance Abuse
w w w w

,Chapter 01: Drug Definitions, Standards, and Information Sources
w w w w w w w



Willihnganz: Clayton’s Basic Pharmacology for Nurses, 18th Edition
w w w w w w w w




MULTIPLE CHOICE w




1. What is the name under which a drug is listed by the US Food and Drug
w w w w w w w w w w w w w w w



wAdministration (FDA)? w



a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C w



The official name is the name under which a drug is listed by the FDA.
w w w w w w w w w w w w w w



The brand name, or trademark, is the name given to a drug by its
w w w w w w w w w w w w w w



manufacturer. The nonproprietary, or generic, name is provided by the
w w w w w w w w w w



United States Adopted Names Council.
w w w w w




DIF: Cognitive Level: Knowledge REF: p. 2 OBJ: 1w w w w w



NAT:NCLEXClient NeedsCategory: Safe, Effective Care Environment
w w w w w w



TOP:NursingProcess Step: Assessment
w CON: Patient Education w w w w




2. Which source contains information specific to nutritional supplements?
w w w w w w w



a. USP Dictionary of USAN & International Drug Names
w w w w w w w



b. Natural Medicines Comprehensive Database
w w w



c. United States Pharmacopoeia/National Formulary (USP NF)
w w w w w



d. Drug Interaction Facts w w




ANS: C w



United States Pharmacopoeia/National Formulary contains information specific to nutritional
w w w w w w w w



supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug
w w w w w w w w w w w w w w



names, pronunciation guide, and possible future FDA approved drugs; it does not include
w w w w w w w w w w w w w



nutritional supplements. Natural Medicines Comprehensive Database contains evidence-based
w w w w w w w w



information on herbal medicines and herbal combination products; it does not include
w w w w w w w w w w w w



information specific to nutritional supplements. Drug Interaction Facts contains comprehensive
w w w w w w w w w w



information on drug interaction facts; it does not include nutritional supplements.
w w w w w w w w w w w




DIF: Cognitive Level: Knowledge REF: p. 2 | p. 3 OBJ: 3 w w w w w w w w



NAT:NCLEXClient NeedsCategory: Physiological Integrity
w w w w



TOP:NursingProcess Step: Assessment
w CON: Nutrition | Patient Education w w w w w w




3. What is the most comprehensive reference available to research a drug interaction?
w w w w w w w w w w w



a. Drug Facts and Comparisons w w w



b. Drug Interaction Facts w w



c. Handbook on Injectable Drugs w w w



d. Martindale—The Complete Drug Reference w w w

, ANS: B w



First published in 1983, Drug Interaction Facts is the most comprehensive book available on
w w w w w w w w w w w w w



drug interactions. In addition to monographs listing various aspects of drug interactions, this
w w w w w w w w w w w w w



information is reviewed and updated by an internationally renowned group of physicians and
w w w w w w w w w w w w w



pharmacists with clinical and scientific expertise.
w w w w w w




DIF: Cognitive Level: Comprehension REF: p. 4 OBJ: 3 w w w w w



NAT:NCLEXClient NeedsCategory: Physiological Integrity
w w w w



TOP:NursingProcess Step: Assessment CON: Safety | Patient Education | Clinical Judgmentw w w w w w w w w




4. The physician has written an order for a drug with which the nurse is unfamiliar. Which section
w w w w w w w w w w w w w w w w



of the Physicians’ Desk Reference (PDR) is most helpful to get information about this drug?
w w w w w w w w w w w w w w w



a. Manufacturer‘s section w



b. Brand and Generic name section w w w w



c. Product category section w w



d. Product information section w w




ANS: B w



A physician‘s order would include the brand and/or generic name of the drug. The alphabetic
w w w w w w w w w w w w w w



index in the PDR would make this section the most user-friendly. Based on a physician‘s order,
w w w w w w w w w w w w w w w w



manufacturer‘s information and classification information would not be known. The
w w w w w w w w w w



Manufacturer‘s section is a roster of manufacturers. The product category section lists products
w w w w w w w w w w w w w



subdivided by therapeutic classes, such as analgesics, laxatives, oxytocics, and antibiotics. The
w w w w w w w w w w w w



product information section contains reprints of the package inserts for the major products of
w w w w w w w w w w w w w w



manufacturers.
w




DIF: Cognitive Level: Comprehension REF: p. 4 OBJ: 3 w w w w w



NAT:NCLEXClient NeedsCategory: Physiological Integrity
w w w w



TOP:NursingProcess Step: Planning CON: Safety | Patient Education | Clinical Judgmentw w w w w w w w w




5. Which online drug reference makes available to healthcare providers and the public a standard,
w w w w w w w w w w w w w



comprehensive, up-to-date look up and downloadable resource about medicines?
w w w w w w w w w



a. American Drug Index w w



b. American Hospital Formulary w w



c. DailyMed
d. Physicians’ Desk Reference (PDR) w w w




ANS: C w



DailyMed makes available to healthcare providers and the public a standard, comprehensive, up-
w w w w w w w w w w w w



to-date look up and downloadable resource about medicines. The American Drug Index is not
w w w w w w w w w w w w w w



appropriate for patient use. The American Hospital Formulary is not appropriate for patient use.
w w w w w w w w w w w w w w



The PDR is not appropriate for patient use.
w w w w w w w w




DIF: Cognitive Level: Knowledge REF: p. 3 | p. 5 w w w w w w w OBJ: 4 w



NAT:NCLEXClient NeedsCategory: Physiological Integrity
w w w w



TOP:NursingProcess Step: Implementation
w w w



CON: Safety | Patient Education | Clinical Judgment
w w w w w w w




6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
w w w w w w w w w w w w w w

, a. Federal Food, Drug, and Cosmetic Act (1938)
w w w w w w



b. Durham Humphrey Amendment (1952) w w w



c. Controlled Substances Act (1970) w w w



d. Kefauver Harris Drug Amendment (1962) w w w w




ANS: A w



The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety
w w w w w w w w w w w w w w w



of all drugs before marketing. Later amendments and acts helped tighten FDA control and ensure
w w w w w w w w w w w w w w w



drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot be used
w w w w w w w w w w w w w w w



safely without medical supervision and restricts their sale to prescription by a licensed
w w w w w w w w w w w w w



practitioner. The Controlled Substances Act addresses only controlled substances and their
w w w w w w w w w w w



categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater drug
w w w w w w w w w w w w



safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products
w w w w w w w w w w w w w w w



before marketing them.
w w w




DIF: Cognitive Level: Knowledge REF: p. 5 w w w w OBJ: 6 w



NAT:NCLEXClient NeedsCategory: Physiological Integrity
w w w w



TOP:NursingProcess Step: Assessment
w w w



CON: Safety | Patient Education | Evidence | Health Care Law
w w w w w w w w w w




7. Meperidine (Demerol) is a narcotic with a high potential for physical and psychological
w w w w w w w w w w w w



dependency. Under which classification does this drug fall?
w w w w w w w w



a. I
b. II
c. III
d. IV
ANS: B w



Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to
w w w w w w w w w w w w w w w w w



severe psychological and physical dependence. Schedule I drugs have high potential for abuse
w w w w w w w w w w w w w



and no recognized medical use. Schedule III drugs have some potential for abuse. Use may lead
w w w w w w w w w w w w w w w w



to low to moderate physical dependence or high psychological dependence. Schedule IV drugs
w w w w w w w w w w w w w



have low potential for abuse. Use may lead to limited physical or psychological dependence.
w w w w w w w w w w w w w w




DIF: Cognitive Level: Comprehension REF: p. 5 OBJ: 2 w w w w w



NAT:NCLEXClient NeedsCategory: Safe, Effective Care Environment
w w w w w w



TOP:NursingProcess Step: Assessment
w CON: Patient Education | Addiction | Pain w w w w w w w w




8. What would the FDA do to expedite drug development and approval for an outbreak of
w w w w w w w w w w w w w w



wsmallpox, for which there is no known treatment?
w w w w w w w



a. List smallpox as a health orphan disease.
w w w w w w



b. Omit the preclinical research phase.
w w w w



c. Extend the clinical research phase. w w w w



d. Fast track the investigational drug.
w w w w




ANS: D w